Posted inGeneral
Disc Medicine Faces Investor Investigations Over FDA Letter
WATERTOWN, MA – September 26, 2026 (STL.News) Disc Medicine Inc. (NASDAQ: IRON) is facing continued scrutiny from multiple securities law firms over disclosures surrounding bitopertin, its experimental treatment for erythropoietic…









